New drug for high cholesterol in adults
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medicine called QLC7401 to lower cholesterol in adults with high cholesterol who are not currently on cholesterol-lowering treatment. It may help reduce the risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your fasting LDL cholesterol is between 2.6 and 4.9 mmol/L.
- You are at low or intermediate risk for heart disease.
- You are not currently taking any cholesterol-lowering medication.
- Your kidney function is adequate (eGFR > 30).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine (QLC7401) that aims to lower LDL ('bad') cholesterol when added to your current cholesterol-lowering therapy. If you are already on a statin but your cholesterol is still not low enough, this trial might help you reach your goals.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests an investigational medicine called QLC7401 for people with a genetic condition called heterozygous familial hypercholesterolemia, which causes very high cholesterol. It aims to see if the new medicine can further lower bad cholesterol when added to your usual cholesterol treatments.
This study tests a combination of two new medications (QCZ484 and inclisiran) designed to lower both blood pressure and cholesterol levels. You may be a good fit if you have high blood pressure and high cholesterol that isn't fully controlled by current treatments.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
Hear when a new Primary Hypercholesterolemia or Mixed Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.